Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
@article{PCM5616, author = {Kartik Sehgal and Andrew J. Piper-Vallillo and Hollis Viray and Adeel M. Khan and Deepa Rangachari and Daniel B. Costa}, title = {Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?}, journal = {Precision Cancer Medicine}, volume = {3}, number = {0}, year = {2020}, keywords = {}, abstract = {}, issn = {2617-2216}, url = {https://pcm.amegroups.org/article/view/5616} }